GLP-1 RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING SAME

Title:

GLP-1 RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING SAME

Document Type and Number:

WIPO Patent Application WO/2022/216094

Kind Code:

A1

Abstract:

The present invention relates to: a novel compound having excellent GLP-1 agonist activity and an excellent DMPK profile, and thus useful as an agent for treating or preventing obesity or various metabolic diseases such as diabetes and hyperlipidemia; an isomer thereof or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound; and a method for preparing the compound.

More Like This:

WO/2007/116061	1-(2-ARYL-2-OXOETHYL)-3-PHENYL-1, 4-DIAZASPIRO [4.5]DEC-3-EN-2-ONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS
JPH02292265	SUBSTITUTED URACIL AND ITS PRODUCTION
JP4335532	MCH antagonists and their use in the treatment of obesity

Inventors:

KIM YOUNG KWAN (KR)
PARK JUN (KR)
JO MIN MI (KR)

Application Number:

PCT/KR2022/005070

Publication Date:

October 13, 2022

Filing Date:

April 07, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

LG CHEMICAL LTD (KR)

International Classes:

C07D401/10; A61K31/4184; A61K31/422; A61K31/4439; A61P3/00; A61P25/28; C07D401/14; C07D405/10; C07D405/14; C07D413/14

Domestic Patent References:

WO2020207474A1	2020-10-15
WO2020263695A1	2020-12-30
WO2018183112A1	2018-10-04
WO2021187886A1	2021-09-23
WO2021154796A1	2021-08-05

Foreign References:

KR20210020095A

2021-02-23

Attorney, Agent or Firm:

LEE & KO IP (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: WEARABLE ELECTRONIC APPARATUS COMPRISING ANTENNA

Next Patent: DRONE FOR EMERGENCY SITUATION AND METHOD FOR CONTROLLING SAME